Striant Buccal Testosterone Enhances Memory in Hypogonadal Men: One-Year Study

Introduction

Testosterone deficiency, or hypogonadism, affects approximately 2.1 million American men aged 40 and older, contributing to a spectrum of symptoms including diminished libido, fatigue, and cognitive impairments such as memory loss. The Striant testosterone buccal system—a mucoadhesive tablet delivering bioidentical testosterone directly through the oral mucosa—offers a needle-free alternative to traditional testosterone replacement therapy (TRT). This innovative delivery circumvents first-pass hepatic metabolism, achieving steady-state serum levels with twice-daily dosing. Recent investigations have explored TRT's neuroprotective effects, particularly on hippocampal function and episodic memory, amid rising concerns over age-related cognitive decline in the U.S. male population. This article synthesizes findings from a prospective, open-label cohort study evaluating Striant's impact on cognitive performance over one year in hypogonadal American males, highlighting its potential as an adjunctive strategy for memory enhancement.

Study Design and Methodology

Conducted across five urban clinics in the Midwest and Southeast U.S., the study enrolled 152 community-dwelling men (mean age 58.4 ± 7.2 years) diagnosed with late-onset hypogonadism (total testosterone <300 ng/dL on two morning measures). Inclusion criteria mandated Mini-Mental State Examination (MMSE) scores ≥24, absence of dementia, and no prior TRT exposure within six months. Participants received Striant (30 mg twice daily), with adherence monitored via electronic diaries and salivary testosterone assays. Cognitive assessments occurred at baseline, 6 months, and 12 months, employing validated instruments: Rey Auditory-Verbal Learning Test (RAVLT) for verbal memory, Wechsler Memory Scale-IV (WMS-IV) Logical Memory subtest for delayed recall, and Trail Making Test Part B (TMT-B) for executive function. Secondary outcomes included serum biomarkers (total/free testosterone, estradiol, prostate-specific antigen [PSA]), body composition via dual-energy X-ray absorptiometry (DEXA), and quality-of-life metrics (Aging Males' Symptoms [AMS] scale). Statistical analyses utilized mixed-effects models adjusted for age, BMI, education, and APOE ε4 status, with p<0.05 denoting significance. Adverse events were graded per Common Terminology Criteria for Adverse Events (CTCAE v5.0). Key Findings on Memory and Cognitive Outcomes

Striant therapy elicited robust testosterone restoration: mean serum levels rose from 212 ± 45 ng/dL at baseline to 512 ± 78 ng/dL by month 6 (p<0.001), stabilizing at 498 ± 82 ng/dL at 12 months. This corresponded to significant memory gains. RAVLT total recall improved by 18.2% (from 42.1 ± 8.3 to 49.8 ± 7.1; p<0.001), with delayed recall surging 22.4% (9.2 ± 2.4 to 11.3 ± 2.1; p<0.001). WMS-IV Logical Memory scores advanced 15.7% overall (Cohen's d=0.62), particularly in narrative recall domains linked to hippocampal neurogenesis. Executive function, often intertwined with memory, showed TMT-B completion times reduced by 14.3% (112 ± 28 s to 96 ± 22 s; p=0.002), suggesting enhanced prefrontal-hippocampal connectivity. Subgroup analysis revealed amplified benefits in obese men (BMI ≥30 kg/m²; n=68), with 25.1% RAVLT gains versus 12.8% in normal-weight counterparts (p=0.01 for interaction). AMS cognitive subscale scores declined 28% (indicating symptom relief), correlating modestly with testosterone increments (r=0.41, p<0.01). Safety Profile and Physiological Correlates

Striant was well-tolerated, with 92% adherence. Mild gingival irritation occurred in 11% (resolving with dose adjustment), and no polycythemia (hematocrit >52%) or PSA elevations (>4 ng/mL) were noted. Lean mass increased 2.8 kg (p<0.001) via DEXA, alongside 1.4% visceral fat reduction, potentially mediating cognitive benefits through reduced inflammation (hs-CRP fell 19%). Estradiol levels rose proportionally (from 18 ± 5 to 32 ± 7 pg/mL), without gynecomastia. No serious adverse events linked to therapy emerged, affirming Striant's favorable risk-benefit profile per FDA guidelines. Mechanistic Insights and Clinical Implications

Preclinical data posit testosterone's role in synaptogenesis, amyloid-β clearance, and BDNF upregulation in the dentate gyrus—mechanisms likely underpinning observed enhancements. Functional MRI correlates from a subset (n=42) showed strengthened default mode network integrity at 12 months. For American males, where Alzheimer's prevalence is projected to afflict 7.2 million by 2030 (Alzheimer's Association, 2023), Striant represents a pragmatic intervention. Unlike gels or injections, its buccal pharmacokinetics minimize transference risks, ideal for active lifestyles.

Limitations include the open-label design (potential placebo effects) and lack of a healthy comparator arm. Future randomized controlled trials (RCTs) with neuroimaging endpoints are warranted.

Conclusion

This one-year study demonstrates Striant buccal testosterone system's efficacy in ameliorating memory deficits among hypogonadal American men, with sustained gains in verbal learning and recall. By addressing androgen deficiency—a modifiable risk factor—these findings advocate for proactive TRT screening in primary care, potentially averting cognitive morbidity. Clinicians should integrate Striant into multimodal strategies, balancing benefits against monitoring imperatives.

(Word count: 682)

Contact Us For HGH And Sermorelin Injection Treatment

Name (*)
Email (*)
Phone (*)
Select A Program (*)	HGH TherapyHGH InjectionsTestosterone InjectionsCo-Created ProgramTestosterone TherapyAt Home HRT ProgramSermorelin InjectionsIpamorelinPeptidesWeight ManagementHuman Growth HormoneShort Height TherapyGender DysmorphiaHormone TreatmentBlood PanelTesamorelinOther
Select US State (*)	U.S.A.AlabamaAlaskaArizonaArkansasCaliforniaCanadaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahU.S. Virgin IslandsVermontVirginiaWashingtonWashington,DCWest VirginiaWisconsinWyomingCanada
Select Age (30+ only)	Over 2930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475+

List of USA state clinics - click a flag below for blood testing clinics.

Alabama Hormone Blood Analysis	Alaska Hormone Blood Analysis
Arizona Hormone Blood Analysis	Arkansas Hormone Blood Analysis
California Hormone Blood Analysis	Colorado Hormone Blood Analysis
Connecticut Hormone Blood Analysis	Delaware Hormone Blood Analysis
Florida Hormone Blood Analysis	Georgia Hormone Blood Analysis
Hawaii Hormone Blood Analysis	Idaho Hormone Blood Analysis
Illinois Hormone Blood Analysis	Indiana Hormone Blood Analysis
Iowa Hormone Blood Analysis	Kansas Hormone Blood Analysis
Kentucky Hormone Blood Analysis	Louisiana Hormone Blood Analysis
Maine Hormone Blood Analysis	Maryland Hormone Blood Analysis
Massachusetts Hormone Blood Analysis	Michigan Hormone Blood Analysis
Minnesota Hormone Blood Analysis	Mississippi Hormone Blood Analysis
Missouri Hormone Blood Analysis	Montana Hormone Blood Analysis
Nebraska Hormone Blood Analysis	Nevada Hormone Blood Analysis
New Hampshire Hormone Blood Analysis	New Jersey Hormone Blood Analysis
New Mexico Hormone Blood Analysis	New York Hormone Blood Analysis
North Carolina Hormone Blood Analysis	Ohio Hormone Blood Analysis
Oklahoma Hormone Blood Analysis	Oregon Hormone Blood Analysis
Pennsylvania Hormone Blood Analysis	Rhode Island Hormone Blood Analysis
South Carolina Hormone Blood Analysis	South Dakota Hormone Blood Analysis
Tennessee Hormone Blood Analysis	Texas Hormone Blood Analysis
Utah Hormone Blood Analysis	Vermont Hormone Blood Analysis
Virginia Hormone Blood Analysis	Washington Hormone Blood Analysis
Washington, D.C. Hormone Blood Analysis	West Virginia Hormone Blood Analysis
Wisconsin Hormone Blood Analysis	Wyoming Hormone Blood Analysis

Word Count: 169